GLEAMER develops a suite of AI solutions for Radiology that encapsulate medical-grade expertise. The company wants to support imaging users to secure diagnoses for all patients and at all times, while improving efficiency. GLEAMER’s AI Companions are directly integrated in the users’ usual reading environment and act as an automated and transparent concurrent reading to improve diagnostic accuracy in X-ray imaging.
GLEAMER’s first AI application BoneView® is the first to get CE Class IIa & FDA 510(k) clearance for traumatic injuries detection on X-rays. The solution is already broadly used in more than 300 public and private hospitals around the globe.
GLEAMER’s second AI module ChestView® launched in 2021 is a CE Class IIa for chest X-ray examination help for practitioners to detects urgent findings or potential tumor findings and improve diagnosis of the readers. The solution is already in use in more than 100 hospitals in Europe.
Co‐founded in 2017 by Christian Allouche, Alexis Ducarouge and Nor‐eddine Regnard MD., GLEAMER raised more than 12 M€ over the past few years for boosting its global expansion and BoneView’s market launches in Europe, Middle East, Asia, and USA.
In parallel, the 50 people company based in Paris has an ambitious product roadmap in many other areas within the radiology to provide medical-grade AI to healthcare institutions.
